Pfizer lifts offer on ResApp deal

03/08/2022 - 16:17

Bookmark

Save articles for future reference.

The agreement between Pfizer and takeover target ResApp has had another revision with an increased cash offer of 20.8 cents per share.

Subscribe to read this article.

Register or login now and receive unlimited access to our award-winning, unbiased and trusted
journalism. Your key to local business, news, insights and data.

Subscribe today for award-winning, unbiased and trusted journalism

Subscription Options